IQZAN HOLDING BERHAD

KLSE (MYR): IQZAN (7183)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.005

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Financial
Market Cap

Market Cap

1 Million

NOSH

222 Million

Latest Quarter

Latest Quarter

31-Dec-2023 [#3]

Announcement Date

21-Feb-2024

Next Quarter

31-Mar-2024

Est. Ann. Date

26-May-2024

Est. Ann. Due Date

30-May-2024

QoQ | YoY

139.14% | 1,461.03%

T4Q Result

Revenue | NP to SH

10,484.000 | -17,269.000

RPS | P/RPS

4.73 Cent | 0.11

EPS | P/E | EY

-7.78 Cent | -0.06 | -1,556.89%

DPS | DY | Payout %

0.00 Cent | 0.00% | 0.00%

NAPS | P/NAPS

0.12 | 0.04

QoQ | YoY

36.52% | -646.61%

NP Margin | ROE

-161.41% | -63.86%

F.Y. | Ann. Date

31-Dec-2023 | 21-Feb-2024

Latest Audited Result

Latest Audited Result

31-Mar-2023

Announcement Date

31-Jul-2023

Next Audited Result

31-Mar-2024

Est. Ann. Date

31-Jul-2024

Est. Ann. Due Date

27-Sep-2024

Annual (Unaudited)

Revenue | NP to SH

16,486.000 | 714.000

RPS | P/RPS

7.43 Cent | 0.07

EPS | P/E | EY

0.32 Cent | 1.55 | 64.37%

DPS | DY | Payout %

0.00 Cent | 0.00% | 0.00%

NAPS | P/NAPS

0.16 | 0.03

YoY

116.81%

NP Margin | ROE

14.96% | 2.01%

F.Y. | Ann. Date

31-Mar-2023 | 26-May-2023

Annualized Result

Revenue | NP to SH

9,528.000 | -22,513.333

RPS | P/RPS

4.29 Cent | 0.12

EPS | P/E | EY

-10.15 Cent | -0.05 | -2,029.69%

DPS | DY | Payout %

-

NAPS | P/NAPS

-

QoQ | YoY

59.07% | -1637.8%

NP Margin | ROE

-232.48% | -83.25%

F.Y. | Ann. Date

31-Dec-2023 | 21-Feb-2024

Business Process

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 8 12.50%
Total Positive Profit Years 1 / 4 25.00% 4 / 8 50.00%
Continuous Quarters Of Positive Profit 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Profit Growth 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Adjusted EPS Growth 1 / 4 25.00% 1 / 8 12.50%
Total Dividend Years 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE -45.70% -23.74%
Average Net Profit Margin -272.83% -143.32%

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Quarters Of Revenue Growth 3 / 5 60.00% 3 / 10 30.00%
Total Positive Profit Years 2 / 5 40.00% 2 / 10 20.00%
Continuous Quarters Of Positive Profit 1 / 5 20.00% 1 / 10 10.00%
Continuous Quarters Of Profit Growth 1 / 5 20.00% 1 / 10 10.00%
Continuous Quarters Of Adjusted EPS Growth 1 / 5 20.00% 1 / 10 10.00%
Total Dividend Years 0 / 5 0.00% 0 / 10 0.00%
Continuous Quarters Of Dividend 0 / 5 0.00% 0 / 10 0.00%
Continuous Quarters Of Dividend Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 5 0.00% 0 / 10 0.00%
Average ROE 1.27% -16.57%
Average Net Profit Margin -1.62% -9.26%
Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 10,484 9,528 16,486 44,250 11,877
NP to SH -17,269 -22,513 714 -6,633 995
Dividend 0 0 0 0 0
Adjusted EPS -7.78 -10.15 0.32 -2.99 0.45
Adjusted DPS 0.00 0.00 0.00 0.00 0.00

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.

Growth

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 42.81% -40.00% -45.65% -0.72% -21.75%
NP to Owner 139.14% 1,461.03% -1,637.80% 345.87% 533.66%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS 139.12% 1,441.94% -1,653.06% 344.19% 530.63%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue -36.41% -11.73% -76.31% -42.21% -19.78% -78.47% 67.35% 38.81% -62.74%
NP to Owner -2,518.63% -1,834.18% -160.34% -3,253.13% -2,360.83% -239.40% 116.81% -28.30% 110.76%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS -2,531.25% -1,831.20% -160.22% -3,271.88% -2,358.57% -239.49% 116.75% -28.79% 110.70%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Discussions
7 people like this. Showing 50 of 1,625 comments

陳 彥霆

if u not confident, please look at the assets of the company, IQZAN has a piece of land in Penang worth RM 22 mil

2021-09-20 13:23

陳 彥霆

MARKET VALUE: RM 23,400,000

No. Plot Nos. 12 &13, Hilir Sungai
Keluang 3, Kawasan Perindustrian
Bayan Lepas Fasa 4, 11900 Bayan
Lepas, Penang.

Particulars of Titles :
Lot Nos. 12370 & 12371 held under
Title Nos. Pajakan Negeri 5891 &
Pajakan Negeri 5867 respectively,
both within Mukim 12, District of
Barat Daya, Pulau Pinang

2021-09-20 13:25

onghenghuat666

you guys still believe in the exit of pn17? director just wanna earn some bucks in the private placement. bought 6 cents + sell for 100% ++ profits. those still trapped good luck!

2021-09-20 14:54

陳 彥霆

don't worry haha, they are just washing those chase high one Wednesday to collect back

2021-09-20 15:20

onghenghuat666

i think might be back to land price as predicted. 7.5 cents before they start pushing again, might be lower

2021-09-20 15:32

陳 彥霆

it's ok, maybe you from JP APEX?

2021-09-20 15:38

陳 彥霆

onghenghuat666 : maybe he want 1000% profit and havent sold?

2021-09-20 19:27

onghenghuat666

陳 彥霆 : yes many maybe, maybe wanna earn last pocket money too. Better collect when there is support, at the moment you can see they are controlling everything. Ikan bilis slowly buying the tickets of the director

2021-09-21 00:17

onghenghuat666

Today another 15%, touching my prediction soon. 7.5 cents back to land price.

2021-09-21 00:18

onghenghuat666

陳 彥霆: so road to land price? 8 cents left.

2021-09-21 09:57

陳 彥霆

should be no issue. my first round already sold with 100% gain. now i am using the profit to buy

2021-09-21 11:15

陳 彥霆

let's see how JP APEX corner this counter

2021-09-21 11:21

onghenghuat666

陳 彥霆 : as predicted, back to 7.5 cents. once 7 cents break, is a bye bye counter.

2021-09-21 16:05

aleesya

Go watch the movie, "The Conman"

2021-09-21 16:53

陳 彥霆

ya , as planned by JP APEX

2021-09-21 17:52

aleesya

This player got no money laa. Cant even push it to high high level. Earn ikan bilis money only.

2021-09-21 20:28

birkincollector

Wah...jumped in at 0.070

2021-09-22 17:12

陳 彥霆

CCB CHEAH CHAY TIONG

2021-09-22 19:09

onghenghuat666

陳 彥霆: so who's right? tomorrow close below 7 cents can say bye bye to the counter, he already done disposing all.

2021-09-22 21:23

陳 彥霆

fxxx this CCB CHEAH CHAY TIONG, useless punter

2021-09-22 22:12

Legend

Today sapuuuuu

2021-09-23 07:03

onghenghuat666

sapu ke bawah most probably

2021-09-23 11:29

陳 彥霆

according to reliable source, this CCB CHEAH he and his family get covid and need money for COVID treatment in private hospital. that's why he is selling his shares. hope this clarifies..

2021-09-23 16:23

onghenghuat666

陳 彥霆 : nice try to get someone to buy up and cover your losses.

2021-09-23 16:38

onghenghuat666

陳 彥霆: Covid treatment so expensive want? Wow you must be a genius to believe in such sources

2021-09-23 21:16

陳 彥霆

onghenghuat666 COVID treatment each person at least 6 digits. some 200-300k

2021-09-27 15:37

陳 彥霆

those 7c all he throw one

2021-09-27 15:44

onghenghuat666

陳 彥霆: so break 7 cents, counter is sleeping soon after he dispose all.

2021-09-27 16:47

BILLC

Post removed.Why?

2021-09-27 16:47

birkincollector

cheah chay tiong took profit....he got into IQZAN in august by subscribing private placement 36mil shares...his cost 0.0675...so this level is pretty safe to get in

2021-09-27 22:15

onghenghuat666

@birkincollector get in for what? stuck for years? this share is not moving normally if you actually go through the volume. Dont look like getting out of PN17 anytime soon.

2021-09-28 10:17

clez91

interesting volumes lately.. monitor MACD signal, could 16 Oct 2020 repeat?

2021-10-12 20:34

RepcoLow2

Nope .......Don't over believe. Game still not started

2021-10-12 22:06

awesome20

iqzan collecting new momentum

2021-10-13 18:30

bleuerouge

golden crossing soon?

2021-10-13 19:40

onghenghuat666

all penthouse emerged, I think director still disposing. Just wait for next banker, thats the only hope la. this stock is dead.

2021-10-13 19:47

gohkimhock

@golengkaki no thanks. I will stay with Dialog..

2021-10-17 11:01

onghenghuat666

@golengkaki you're staying @ penthouse too?

2021-10-18 00:06

DreamEmperor

Got any interesting turnaround story geh

2021-10-18 02:56

DreamEmperor

If got very good lor

2021-10-18 02:56

DreamEmperor

Dialog usually a slow dancer

usually

2021-10-18 02:58

bleuerouge

people keep throwing…adios.

2021-10-18 18:14

Legend

siapa sudah tulis itu article..manyak suwey lo..haha

2021-10-18 22:21

bleuerouge

better skip this counter, don’t get trap ya.

2021-10-19 23:08

firdhaus19

Post removed.Why?

2021-10-19 23:15

nixonteh85

let's have some fun

2021-11-26 01:25

shkam1201

Engine started.......??

2022-04-21 10:20

kyosan

lets go...

2022-11-24 15:28

Dehcomic01

No two companies are alike. Even if they are classified into the same sector, there are differences in products and markets. That is why I avoid relative valuation using PE or other multiples as it can give a wrong picture. If you are going to compare companies then compare business performance. When I compared IQZAN with my packaging benchmark such as New Toyo or Canone, I found that IQZAN performance was the worst. Not exactly a good picture from a fundamental perspective. For a quick video take of New Toyo go to https://www.youtube.com/watch?v=zuL2PB7Kwkg

2023-08-28 11:37

Post a Comment